BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc. (BBIO)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
76. 57
-0.02
-0.0261%
$
15B Market Cap
- P/E Ratio
- Div Yield
1.45M Volume
-3.85 Eps
$ 76.59
Previous Close
Add Transaction
Day Range
76.22 77.45
Year Range
48.78 93.42
Want to track BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BridgeBio Pharma, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
David R. Hess
David R. Hess Wealth Management Associates Inc.
10,754 $426,890.05 $861,287.82 $434,397.77 101.76%
Nicole Reese
Nicole Reese WPG Advisers LLC
115 $8,787.48 $9,428.85 $641.37 7.3%
HFM Investment Advisors LLC
HFM Investment Advisors LLC HFM Investment Advisors LLC
9 $363.33 $720.81 $357.48 98.39%